Board Meeting19 May 2026, 05:31 pm
Gennex Labs Board Meeting on 30 May 2026 to Approve Results
AI Summary
Gennex Laboratories Ltd has scheduled a Board of Directors meeting on May 30, 2026, to consider and approve the audited financial statements (standalone and consolidated) for the quarter and year ended March 31, 2026. The meeting will also address the Independent Reports of the Statutory Auditor on these financial statements. The trading window, which was closed on April 1, 2026, will reopen 48 hours after the declaration of the audited financial results.
Key Highlights
- Board meeting scheduled for May 30, 2026, to approve audited financial statements.
- Consideration of Independent Reports of the Statutory Auditor.
- Trading window to reopen 48 hours after results declaration.
- Meeting to be held at the Corporate Office of the Company at 04:00 PM.
Price Impact
More from GENNEX